Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-01-07

FDA Approved: CEFDINIR — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves an Abbreviated New Drug Application for cefdinir from BluePoint Laboratories, indicating the availability of a generic cefdinir product. This marks…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefdinir (cefdinir)

Snippet

ORIG AP for CEFDINIR (CEFDINIR)